Pharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law,

NJ 2019 Independent Pharmacies
DOJ False Claims Act Conspiracy
Penalty
$225,000

Outcome

Pharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law, Resolves Related False Claims Act Violations

Details

Pharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law, — DOJ Enforcement (2019)

Outcome: Pharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law, Resolves Related False Claims Act Violations

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.

Source: DOJ Press Release — Pharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law, Resolves Related False Claims Act Violations

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works